To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
TowerBrook acquires Clariant unit
The London and New York-based private equity firm has acquired Clariant’s pharmaceuticals fine chemicals business for €70m.
